GERCOR
Welcome,         Profile    Billing    Logout  
 1 Trial 
2 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
GRAMONT, Aimery DE
CHIMOVIP, NCT03025477: Two Therapeutic Strategies in First-line in Patients With Epithelial Advanced Ovarian Cancer

Recruiting
2
84
Europe
CC0 - Carboplatin (IV) - Paclitaxel (IV), CC0 - Cisplatin (IP) - Epirubicin (IV), CC>0 - Carboplatin (IV)- Paclitaxel (IV), CC>0 - Cisplatin (IP/IV)- Epirubicin (IV)
Groupe Hospitalier Diaconesses Croix Saint-Simon, GERCOR - Multidisciplinary Oncology Cooperative Group
Ovarian Cancer, Epithelial
10/21
10/32
NCT02979483: Management of Symptomatic Advanced Pancreatic Adenocarcinoma

Active, not recruiting
N/A
110
Europe
14-EISCP
GERCOR - Multidisciplinary Oncology Cooperative Group
Pancreas, Management Supportive Care Program
07/22
04/25
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
GRAMONT, Aimery DE
CHIMOVIP, NCT03025477: Two Therapeutic Strategies in First-line in Patients With Epithelial Advanced Ovarian Cancer

Recruiting
2
84
Europe
CC0 - Carboplatin (IV) - Paclitaxel (IV), CC0 - Cisplatin (IP) - Epirubicin (IV), CC>0 - Carboplatin (IV)- Paclitaxel (IV), CC>0 - Cisplatin (IP/IV)- Epirubicin (IV)
Groupe Hospitalier Diaconesses Croix Saint-Simon, GERCOR - Multidisciplinary Oncology Cooperative Group
Ovarian Cancer, Epithelial
10/21
10/32
NCT02979483: Management of Symptomatic Advanced Pancreatic Adenocarcinoma

Active, not recruiting
N/A
110
Europe
14-EISCP
GERCOR - Multidisciplinary Oncology Cooperative Group
Pancreas, Management Supportive Care Program
07/22
04/25

Download Options